Exposure to Glucagon-Like Peptide 1 Receptor Agonists Does Not Increase the Risk of AKI Associated with Anticancer Therapy

Authors: Swetha Rani Kanduri, Rosemary Kovacic, Gavin R. Skipper, Juan Carlos Q. Velez

Published: 2024-10-28

DOI: 10.1681/asn.2024x8y8t8d2

Keywords: No keywords found.

Abstract:
No abstract found.

Source: